The FDA is poised to approve Alnylam's first-ever RNA interference drug - STAT

The FDA is poised to approve Alnylam's first-ever RNA interference drug - STAT

The FDA is poised to approve the first-ever drug that mutes disease-causing genes

By KATE SHERIDAN @sheridan_kate

AUGUST 7, 2018

The widely anticipated approval will be a watershed moment not only for the drug's manufacturer, but also for the broader field of research into RNAi.

READ MORE